Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Moodie

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The New Zealand Medical Journal|June 28, 2005
PHARMAC responds to the RMI's editorialPeter Moodie, Wayne McNee
The New Zealand Medical Journal|March 7, 2007
PHARMAC and statins--correction is neededScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|March 20, 2012
National prescribing data for dabigatranScott Metcalfe, Peter Moodie
BMJ (Clinical Research Ed.)|September 24, 1988
Scrutinising research ethics committeesTim Marshall, Peter Moodie
The New Zealand Medical Journal|February 25, 2006
PHARMAC's response on clopidogrelPeter Moodie, Sean Dougherty
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising--yes it can compromise patient healthScott Metcalfe, Wayne McNee, Peter Moodie
The New Zealand Medical Journal|July 20, 2005
PHARMAC welcomes debatePeter Moodie, Wayne McNee, Scott Metcalfe
The New Zealand Medical Journal|March 27, 2003
Response from PHARMAC: difficult choicesPeter Moodie, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 27, 2006
PHARMAC and statins--getting the best population health gainsPeter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal|June 28, 2005
PHARMAC and tobacco control in New Zealand: two licensed funded options are already availableScott Metcalfe, Peter Moodie, Wayne McNee
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|June 28, 2005
PHARMAC responds to the RMI's editorialPeter Moodie, Wayne McNee
The New Zealand Medical Journal|March 7, 2007
PHARMAC and statins--correction is neededScott Metcalfe, Peter Moodie
The New Zealand Medical Journal|March 20, 2012
National prescribing data for dabigatranScott Metcalfe, Peter Moodie
BMJ (Clinical Research Ed.)|September 24, 1988
Scrutinising research ethics committeesTim Marshall, Peter Moodie
The New Zealand Medical Journal|February 25, 2006
PHARMAC's response on clopidogrelPeter Moodie, Sean Dougherty
The New Zealand Medical Journal|October 29, 2003
Direct-to-consumer advertising--yes it can compromise patient healthScott Metcalfe, Wayne McNee, Peter Moodie
The New Zealand Medical Journal|July 20, 2005
PHARMAC welcomes debatePeter Moodie, Wayne McNee, Scott Metcalfe
The New Zealand Medical Journal|March 27, 2003
Response from PHARMAC: difficult choicesPeter Moodie, Scott Metcalfe, Wayne McNee
The New Zealand Medical Journal|July 27, 2006
PHARMAC and statins--getting the best population health gainsPeter Moodie, Sean Dougherty, Scott Metcalfe
The New Zealand Medical Journal|June 28, 2005
PHARMAC and tobacco control in New Zealand: two licensed funded options are already availableScott Metcalfe, Peter Moodie, Wayne McNee
Pageof 4